This is a paradigm shift in how we approach the most ‘untreatable’ cancers”— John Warlick, Founder of Immunosonics ...

Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, today announced translational data from the GOBLET and AWARE-1 trials will be ...

Proceeds from the May 22 concert will go toward research on a rare genetic disorder affecting a Redlands girl.

GLP-1 drugs like Ozempic and Wegovy offer surprising benefits beyond weight loss, but also carry unexpected risks.

The registrational intent ACR-368 Phase 2b study is advancing with a prespecified simultaneous interim analysis and data update for both ...

Objectives Owing to the underrepresentation of early-stage disease in randomised trials and inconsistent clinical evidence, ...

Americans Skip Overseas Travel as Stem Cell Exosome Therapy Lands at 5 U.S. Locations New York, United States - May 14, ...

The Justice Department claims that clinics used fake diagnoses and kickbacks to parents to bring children into treatment.

Texas orders first U.S. detransition clinic in $10M settlement with hospital.

College students with anxiety, depression and eating disorders may be more likely to start and to respond more positively to ...